Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary EPO during reperfusion for first ST-elevation myocardial infarction
2007-003509-28Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Jul 2008
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of darbepoetin alfa in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Myocardial infarct size. Started Jul 2008; status: active.
02
Drugs
darbepoetin alfa
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2007-003509-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003509-28.